Loading clinical trials...
Loading clinical trials...
Clinical Evaluation of Efficacy and Safety of FS VH S/D 500 S-apr for Hemostasis in Subjects Undergoing Vascular Surgery
Conditions
Interventions
Fibrin Sealant, Vapor Heated, Solvent/Detergent-treated with 500 IU/ml thrombin and synthetic aprotinin (FS VH S/D 500 s-apr)
Surgical gauze pads
Locations
22
United States
Birmingham, Alabama, United States
Tucson, Arizona, United States
Fresno, California, United States
Orange, California, United States
Washington D.C., District of Columbia, United States
Jacksonville, Florida, United States
Start Date
July 1, 2009
Primary Completion Date
October 1, 2010
Completion Date
November 1, 2010
Last Updated
November 27, 2012
Lead Sponsor
Baxter Healthcare Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions